FDA Budget Issues Creep Into Strategic Priorities-thegraysheet: Budget constraints will have an increasing focus as FDA makes strategic decisions in the coming years. Agency officials included stewardship, such as doing more with less funding, among the cross-cutting strategic priorities in its draft strategic priorities document (PDF) for 2014-2018, alongside regulatory science, globalization, product safety and quality, and smart regulation. It appears to be a recognition that while FDA and its stakeholders fight on Capitol Hill to increase the budget, the agency cannot continue to expect an ideal funding level for all its needs.
